Ghent University Academic Bibliography

Journal Article
A1
open access

Ustekinumab in ulcerative colitis : a real-life effectiveness study across multiple Belgian centers (SULTAN)

Tom Holvoet, Marie Truyens (UGent) , Catherine Reenaers, Filip Baert, Stijn Vanden Branden, Anneline Cremer, Lieven Pouillon, Pieter Dewint, Wouter Van Moerkercke, Jean-François Rahier, et al.

(2025) JOURNAL OF CLINICAL MEDICINE. 14(18).

Add to list

Journal Article
A1
open access

Perianal fistulizing Crohn’s disease : utilizing the TOpClass classification in clinical practice to provide targeted individualized care

Luke N. Hanna, Sulak Anandabaskaran, Nusrat Iqbal, Jeroen Geldof, Jean-Frédéric LeBlanc, Anders Dige, Lilli Lundby, Séverine Vermeire, André D’Hoore, Bram Verstockt, et al.

(2025) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 23(6). p.914-926

Add to list

Journal Article
A1
open access

The effectiveness of second-and-third line biologics in perianal Crohn’s disease : a multicenter propensity score-matched study

Uria Shani, Monica State, Radu Bogdan Mateescu, Ana-Maria Davidoiu, Lucian Negreanu, Isabel Silva, Fernando Magro, Charlie W Lees, Nikolas Plevris, Xavier Roblin, et al.

(2025) JOURNAL OF CROHNS & COLITIS. 19(6).

Add to list

From reactive to predictive : advancing biologic dosing in dermatology

Anke Eylenbosch (UGent) , Ruoheng Wei, Rani Soenen (UGent) , Catherine Smith, Joseph F. Standing, Satveer Mahil and Jo Lambert (UGent)

(2025) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY.

Add to list

Journal Article
A1
open access

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update

Laure Gossec, Andreas Kerschbaumer, Ricardo J. O. Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B. Mcinnes, Dennis Mcgonagle, et al.

(2024) ANNALS OF THE RHEUMATIC DISEASES. 83(6). p.706-719

Add to list

Journal Article
A1
open access

Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study

Tom Holvoet, Marie Truyens (UGent) , Cara De Galan, Harald Peeters (UGent) , Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui-Amezaga, Rocio Ferreiro-Iglesias, et al.

(2024) JOURNAL OF CLINICAL MEDICINE. 13(2).

Add to list

Journal Article
A1
open access

Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study

Ahmad Albshesh, Lian Bannon, Tali Sharar Fischler, Marie Truyens (UGent) , Stephan R. Vavricka, Katja Tepes, Daniela Pugliese, Edoardo V. Savarino, Eran Zittan, David Drobne, et al.

(2023) JOURNAL OF CLINICAL MEDICINE. 12(7).

Add to list

Journal Article
A1
open access

Long‐term efficacy and safety of brodalumab in moderate‐to‐severe plaque psoriasis : a post hoc pooled analysis of AMAGINE‐2 and ‐3

K. Reich, L. Iversen, L. Puig, Jo Lambert (UGent) , U. Mrowietz, K. Kaplan Saday and R.B. Warren

(2022) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 36(8). p.1275-1283

Add to list

Journal Article
A1
open access

Dermatology life quality index in patients with moderate-to-severe plaque psoriasis treated with Brodalumab or Ustekinumab

Jo Lambert (UGent) , Jes Birger Hansen, Anne Sohrt and Luis Puig

(2021) DERMATOLOGY AND THERAPY. 11(4). p.1265-1275

Add to list

Journal Article
A1
open access

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis : study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study : the BeNeBio study

Lara S. van der Schoot, Juul M. P. A. van den Reek, Lynda Grine (UGent) , Lisa Schots, Wietske Kievit, Jo Lambert (UGent) and Elke M. G. J. de Jong

(2021) TRIALS. 22(1).

Academic Bibliography

Ustekinumab in ulcerative colitis : a real-life effectiveness study across multiple Belgian centers (SULTAN)

Perianal fistulizing Crohn’s disease : utilizing the TOpClass classification in clinical practice to provide targeted individualized care

The effectiveness of second-and-third line biologics in perianal Crohn’s disease : a multicenter propensity score-matched study

From reactive to predictive : advancing biologic dosing in dermatology

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update

Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study

Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study

Long‐term efficacy and safety of brodalumab in moderate‐to‐severe plaque psoriasis : a post hoc pooled analysis of AMAGINE‐2 and ‐3

Dermatology life quality index in patients with moderate-to-severe plaque psoriasis treated with Brodalumab or Ustekinumab

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis : study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study : the BeNeBio study

Contents

Support

Contact